Cross-sectional analysis of national testosterone prescribing through prescription drug monitoring programs, 2018-2022.

Background: For two decades preceding the COVID-19 pandemic, testosterone therapy (TT) became more prevalent in the US. Given the forced shift in practice patterns and healthcare accessibility during the pandemic, it was unclear how TT utilization would change.

Objective: To assess the change in testosterone prescriptions nationally.